Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age
Recruiting
Phase 4
Interventional Study
Bronchiolitis Acute Viral
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 6 Months – 24 Months
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 210 (estimated)
- Sponsor
- University of Oulu · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the trial is to evaluate whether the use of oral prednisolone directed by point-of-care testing is useful in acute wheezing caused by rhinovirus in children aged 6-24 months.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Wheezing bronchitis diagnosed by a physician
* Need for salbutamol treatment at the emergency department
* Positive nasopharyngeal rhinovirus or picornavirus finding in point-of-care testing
Exclusion Criteria:
* Need for immediate resuscitation
* Immediate transfer to ICU
*…
Contacts